• EX 527 and SIRT1: Evidence, Mechanism, Boundaries

  2026-10-15

  A source-bounded overview of EX 527 (SEN0014196), covering its documented identity, reported SIRT1 inhibition, assay meaning, downstream p53 readouts, and the limits imposed by the absence of an identity-matched research paper.

• CA-074: Product Identity and Evidence Boundaries

  2026-10-14

  APExBIO lists CA-074 (SKU A1926) as a selective cathepsin B inhibitor, with a catalog-reported Ki of 2–5 nM and substantially weaker reported affinity for cathepsins H and L. The same product description associates CA-074 with neurotoxicity reduction via cathepsin B inhibition, immune response modulation, and reduced metastasis in a breast cancer mouse model. Because the source is a product description rather than an identity-matched primary research report, these claims define a mechanistic and conceptual research scope, not independently verified efficacy, selectivity, or translational performance.

• Q-VD-OPh in Context: Caspases and Mitophagy

  2026-10-14

  The reported Rab14 study advances a cell-based model in which Rab14 supports Parkin-dependent mitophagy through organelle-contact mechanisms. Q-VD-OPh is relevant to apoptosis research as a supplier-described pan-caspase inhibitor, but the supplied evidence does not show that it was used in the Rab14 study or establish a direct link between Q-VD-OPh and Rab14-mediated mitophagy.

• Acetoacetic Acid Sodium Salt: Evidence Boundaries

  2026-10-13

  A source-grounded overview of sodium acetoacetate, its conceptual relevance to ketone-body biology, and the limits of the supplied evidence for diabetes and metabolic research.

• MCL-1 Dependence in Breast Cancer: Evidence and Limits

  2026-10-13

  Campbell and colleagues found that established breast tumors depended on MCL-1’s canonical anti-apoptotic function, with tumor effects requiring BAX and BAK. These findings support MCL-1 as a cancer research target but do not establish that A-1210477 reproduces the study’s results or has clinical efficacy.

• TRPM3 Regulation: What the Structure Shows

  2026-10-12

  Yin et al. use cryo-EM and complementary functional analyses to examine how pregnenolone sulfate, a synthetic agonist and primidone regulate the TRPM3 ion channel. The study provides a structural framework for ligand recognition and gating, but it does not establish clinical efficacy, macrophage biology or any connection to PBS Liposomes.

• Sphingosine-1-phosphate: Evidence and Boundaries

  2026-10-12

  S1P signaling is receptor- and context-dependent: supplied preclinical evidence links S1PR3 to neuronal apoptosis after experimental intracerebral hemorrhage, while the commercial description emphasizes broader vascular and survival signaling. The findings are mechanistically informative but do not establish clinical efficacy or a universal effect of S1P on apoptosis.

• Nanoparticle Uptake in Corneal Epithelial Cells

  2026-10-11

  Azadi and David examined how nanoparticle size and surface chemistry influence uptake by human corneal epithelial cells in a mucosa-aware in vitro model. Their results support energy-dependent endocytosis, particularly macropinocytosis and caveolae-associated uptake, but the study does not establish therapeutic efficacy, safety in humans, or performance across an intact eye.

• Hoechst 33342 in Dermal Senescence Research

  2026-10-10

  A source-grounded overview of how Hoechst 33342 may support nuclear visualization in dermal fibroblast senescence research, using Zhou et al. (2025) as the central study. The article separates direct findings from conceptual applications, evaluates evidence for pterostilbene-mediated mitochondrial quality control, and outlines limitations that restrict translation to human skin or clinical anti-aging claims.

• Cisplatin in HNSCC: Evidence and Research Context

  2026-10-09

  A source-grounded overview of Cisplatin (CDDP) in head and neck squamous cell carcinoma research, with emphasis on DNA damage, chemotherapy resistance, SIA-cIgG/PTPN13 biology, model comparisons, and translational limitations.

• Acetylspiramycin: Evidence, Uses, and Limits

  2026-10-09

  Acetylspiramycin, also called Spiramycin B, is described as a 16-membered macrolide and ribosomal targeting agent. The supplied clinical evidence is limited to a single case of refractory ocular toxoplasmosis in which Toxoplasma gondii and HHV-7 DNA were detected together. This overview separates catalog claims from published findings, explains conceptual research applications, and outlines important limits for antimicrobial resistance research and immune modulation studies.

• Brefeldin A: From Trafficking to Translational Insight

  2026-10-08

  Brefeldin A is more than a vesicle transport inhibitor: it is a mechanistic probe for the relationship between ER–Golgi trafficking, proteostasis, stress signaling, and cell fate. This thought-leadership analysis connects BFA research in cancer models with the endothelial-injury findings reported for moesin in sepsis, while clearly separating established evidence from forward-looking translational hypotheses.

• Acetaminophen and ATTR-CM: A Translational Divide

  2026-10-08

  Acetaminophen and paracetamol can serve as informative pharmacology references for COX-2-associated signaling, oxidative stress, hepatotoxicity research, and ferroptosis-related phenotypes. However, they do not reproduce the gene-silencing logic of emerging siRNA, antisense oligonucleotide, or CRISPR-Cas9 strategies for transthyretin amyloid cardiomyopathy. This article defines the mechanistic boundary and shows how translational researchers can use that distinction to build stronger evidence packages.

• Biodegradable Polyesters for VEGF mRNA Delivery

  2026-10-07

  A 2026 Chemical Engineering Journal study reports three-armed biodegradable polyesters designed to combine mRNA-complexing behavior with degradable chemistry and intrinsic redox-related bioactivity. In critical limb ischemia models, arginine-functionalized nanoparticles carrying VEGF mRNA showed improved transfection and pro-angiogenic effects compared with selected conventional lipid nanoparticle controls, although clinical translation remains unestablished.

• Microplastics, Vitamin B6, and PCOS: Study Analysis

  2026-10-07

  A recent mouse study identifies a gut microbiota–vitamin B6–ovary axis through which polystyrene microplastics worsened features of a DHEA-induced PCOS model. The findings connect microbial disruption, micronutrient depletion, ovarian inflammation, oxidative stress, and reproductive dysfunction, while vitamin B6 rescue supports—but does not conclusively prove—a causal nutritional mechanism.

8600 records 4/574 page Previous Next 12345 下5页 Last page